IP Library Granted Patent US 11,919,950
Granted Patent B2
US 11,919,950 · App. 17/122,752 · Granted Mar 5, 2024

Expression vector encoding antibody molecule which binds IL-17A and IL-17F

Inventors: Ralph Adams (Slough, GB); Terence Seward Baker (Slough, GB); Alastair David Griffiths Lawson (Slough, GB)
Assignee: UCB BIOPHARMA SRL
C07K16/244C07K2317/33C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,919,950
App. No.
17/122,752
Granted
Mar 5, 2024
Kind
B2
Abstract

The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.

Claims (8)

1. An expression vector comprising the nucleic acid sequence set forth in SEQ ID NO: 14.

2. The expression vector of claim 1 , further comprising the nucleic acid sequence set forth in SEQ ID NO: 10.

3. A host cell comprising the expression vector of claim 1 .

4. A method comprising culturing the host cell of claim 3 under conditions suitable for the expression of the nucleic acid.

5. The host cell of claim 3 , wherein the expression vector further comprises the nucleic acid sequence set forth in SEQ ID NO: 10.

6. A method comprising culturing the host cell of claim 5 under conditions suitable for the expression of the nucleic acids.

7. The host cell of claim 3 , further comprising an expression vector comprising the nucleic acid sequence set forth in SEQ ID NO: 10.

8. A method comprising culturing the host cell of claim 7 under conditions suitable for the expression of the nucleic acids.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2021
From: ADAMS, RALPH; BAKER, TERENCE SEWARD; LAWSON, ALASTAIR DAVID GRIFFITHS
To: UCB PHARMA S.A.
Reel/Frame 055496/0556 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2021
From: UCB PHARMA S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 055496/0675 →
CHANGE OF NAME Recorded Mar 4, 2021
From: UCB BIOPHARMA SPRL
To: UCB BIOPHARMA SRL
Reel/Frame 055506/0133 →
Continuity (6)
Continuation 15974407 · May 8, 2018
Continuation 14690892 · Apr 20, 2015
Division 14074880 · Nov 8, 2013
Division 13348456 · Jan 11, 2012
Provisional Application 61432814 · Jan 14, 2011
Related Publication 20210309734A1 · Oct 7, 2021
Cited By (1)
US 12,715,914